PASGPassage BIO, Inc.vs its industry peers
A metric-by-metric comparison of Passage BIO, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PASGThis | $15M#2 | — | 3.4x#2 | — | — | 29.7%#1 | — | -1021.6%#2 | — | — | -35.7%#1 | — |
| QNCX | $28M#1 | 0.2x#2 | — | — | — | -47.8%#3 | — | — | — | — | — | — |
| DYAI | $13M#3 | — | — | 4.3x#1 | -11.6%#1 | -26.8%#2 | -232.8%#1 | — | — | — | -63.0%#2 | — |
| ENGNW | $12M#4 | 0.1x#1 | 0.1x#1 | — | — | -112.7%#4 | — | -50.9%#1 | — | — | -72.8%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice